FDA's release Thursday (Dec. 18) of a long-awaited drug electronic labeling proposed rule that would require prescription drug makers to distribute prescribing information electronically, eliminating the paper form, goes against Senate appropriators' request earlier this year, but is praised by generic drug makers who tout the electronic labeling plan as an alternative to a separate generic drug labeling rule they strongly oppose. The Generic Pharmaceutical Association earlier this year suggested that the electronic labeling rule, which had been under review...